Zenas BioPharma, Inc. (ZBIO) NASDAQ
21.05
-0.29(-1.36%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
21.05
-0.29(-1.36%)
Currency In USD
| Market Cap | 1.62B |
| Enterprise Value | 1.59B |
| P/E Ratio | -2.59 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 93.97 |
| Price/Book Ratio | 4.04 |
| Enterprise/Revenue | 90.91 |
| Enterprise/EBITDA | -4.29 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -37.77 |
| Operating Margin | -21.64 |
| Return On Assets | -0.98 |
| Return On Equity | -1.57 |
| Revenue | 10M |
| Revenue/Share | 0.22 |
| Gross Profit | 9.94M |
| EBITDA | -211.33M |
| Net Income | -377.74M |
| Diluted EPS | -8.44 |
| Total Cash | 343.19M |
| Total Cash/Share | 7.38 |
| Total Debt | 79.96M |
| Total Debt/Equity | 0.33 |
| Current Ratio | 5.61 |
| Book Value Per Share | 5.21 |
| 52-Week Change | 141.4 |
| 52-Week High | 44.6 |
| 52-Week Low | 8.16 |
| Moving Average 50 Days | 23.27 |
| Moving Average 200 Days | 23.69 |
| Average Volume | 798,670 |
| Shares Outstanding | 44.64M |
| % Held by Institutions | 98.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |